Citation Impact
Citing Papers
Probing mucin-type O-linked glycosylation in living animals
2006 StandoutNobel
The Microbial Metabolites, Short-Chain Fatty Acids, Regulate Colonic T reg Cell Homeostasis
2013 StandoutScience
Molecular-phylogenetic characterization of microbial community imbalances in human inflammatory bowel diseases
2007 Standout
Programmed cell death 1 ligand 1 and tumor-infiltrating CD8 + T lymphocytes are prognostic factors of human ovarian cancer
2007 StandoutNobel
Induction of Colonic Regulatory T Cells by Indigenous Clostridium Species
2010 StandoutScience
Faecalibacterium prausnitzii is an anti-inflammatory commensal bacterium identified by gut microbiota analysis of Crohn disease patients
2008 Standout
Comprehensive genomic characterization of head and neck squamous cell carcinomas
2015 StandoutNature
HER2 in situ hybridization in breast cancer: clinical implications of polysomy 17 and genetic heterogeneity
2013
Recommendations for Human Epidermal Growth Factor Receptor 2 Testing in Breast Cancer: American Society of Clinical Oncology/College of American Pathologists Clinical Practice Guideline Update
2013 Standout
The urgent need to recover MHC class I in cancers for effective immunotherapy
2016
Anti-Inflammatory Actions of Neuroprotectin D1/Protectin D1 and Its Natural Stereoisomers: Assignments of Dihydroxy-Containing Docosatrienes
2006
Elements of cancer immunity and the cancer–immune set point
2017 StandoutNature
Chimeric Antigen Receptor–Modified T Cells for Acute Lymphoid Leukemia
2013 Standout
Inflammation and cancer
2002 StandoutNature
Papillomaviruses and Cancer of the Upper Digestive and Respiratory Tracts
1994
Disease-Specific Induced Pluripotent Stem Cells
2008 Standout
Prognostic significance of T-cell infiltrates, expression of β2-microglobulin and HLA-DR antigens in breast carcinoma
1994
Pro-resolving lipid mediators are leads for resolution physiology
2014 StandoutNature
Chromosomal Abnormalities in Embryonic and Somatic Stem Cells
2015
Cancer immunotherapy: breaking the barriers to harvest the crop
2004 StandoutNobel
Genome-Scale CRISPR-Mediated Control of Gene Repression and Activation
2014 Standout
Down-regulation of the MHC class I antigen-processing machinery after oncogenic transformation of murine fibroblasts
1998
The Hallmarks of Cancer
2000 Standout
Interferon-? and -?, but not tumor necrosis factor-?, demonstrate immunoregulatory effects on carcinoma cell lines infected with human papillomavirus
1997
Cumulative Haploinsufficiency and Triplosensitivity Drive Aneuploidy Patterns and Shape the Cancer Genome
2013
Differentiation of Embryonic Stem Cells to Clinically Relevant Populations: Lessons from Embryonic Development
2008
Immunology and immunotherapy of colorectal cancer
2003
Current Understanding of the Mechanisms Underlying Immune Evasion From PD-1/PD-L1 Immune Checkpoint Blockade in Head and Neck Cancer
2020
Molecular and Genetic Properties of Tumors Associated with Local Immune Cytolytic Activity
2015 Standout
Structure, dynamics and functions of promyelocytic leukaemia nuclear bodies
2007
Papillomaviruses and cancer: from basic studies to clinical application
2002 StandoutNobel
CD98hc (SLC3A2) Interaction with β1 Integrins Is Required for Transformation
2004
Short-chain fructooligosaccharides, in spite of being fermented in the upper part of the large intestine, have anti-inflammatory activity in the TNBS model of colitis
2006
Formation of Arabidopsis Cryptochrome 2 Photobodies in Mammalian Nuclei
2013 StandoutNobel
Neo-antigens predicted by tumor genome meta-analysis correlate with increased patient survival
2014
Correlation between in vitro and in vivo immunomodulatory properties of lactic acid bacteria
2007
Tumor antigen-specific T helper cells in cancer immunity and immunotherapy
2005
The Impact of the Gut Microbiota on Human Health: An Integrative View
2012 Standout
Cell adhesion molecules of the immunoglobulin supergene family and their role in malignant transformation and progression to metastatic disease
1991
Chronic immune activation and inflammation in the pathogenesis of aids and cancer
2002
Phase transitions in the assembly of multivalent signalling proteins
2012 StandoutNature
Donor leukocyte infusions in acute lymphocytic leukemia
2000
Primary, Adaptive, and Acquired Resistance to Cancer Immunotherapy
2017 Standout
Total loss of MHC class I in colorectal tumors can be explained by two molecular pathways: β2‐microglobulin inactivation in MSI‐positive tumors and LMP7/TAP2 downregulation in MSI‐negative tumors
2003
Effects of dietary fiber on inflammatory bowel disease
2005
TAP off - tumors on
1997
The blockade of immune checkpoints in cancer immunotherapy
2012 Standout
Innovation in the culture and derivation of pluripotent human stem cells
2008
Single-Cell Transcriptomic Analysis of Primary and Metastatic Tumor Ecosystems in Head and Neck Cancer
2017 Standout
Disrupted dichotomous intracellular control of human papillomavirus infection in cancer of the cervix
1994 StandoutNobel
Targeted therapy of solid malignancies via HLA class II antigens: a new biotherapeutic approach?
2003
Characterization of the Oligosaccharides Associated with the Human Ovarian Tumor Marker CA125
2003
Immunotherapy of Diffuse Gliomas: Biological Background, Current Status and Future Developments
2009 Standout
IFNγ and lymphocytes prevent primary tumour development and shape tumour immunogenicity
2001 StandoutNature
MHC antigens and tumor escape from immune surveillance
2001
Phylogenetic Classification of Human Papillomaviruses: Correlation With Clinical Manifestations
1992
Matrix Crosslinking Forces Tumor Progression by Enhancing Integrin Signaling
2009 Standout
Epidemiologic Classification of Human Papillomavirus Types Associated with Cervical Cancer
2003 Standout
A sensitivity scale for targeting T cells with chimeric antigen receptors (CARs) and bispecific T-cell Engagers (BiTEs)
2012
MHC class I antigen processing pathway defects, ras mutations and disease stage in colorectal carcinoma
2003
Principles of Cancer Therapy: Oncogene and Non-oncogene Addiction
2009 Standout
The gut microbiota shapes intestinal immune responses during health and disease
2009 Standout
Escape of Human Solid Tumors from T–Cell Recognition: Molecular Mechanisms and Functional Significance
1999
Manipulation of T cell costimulatory and inhibitory signals for immunotherapy of prostate cancer
1997 StandoutNobel
Type, Density, and Location of Immune Cells Within Human Colorectal Tumors Predict Clinical Outcome
2006 StandoutScience
Selecting Lactic Acid Bacteria for Their Safety and Functionality by Use of a Mouse Colitis Model
2006
Regulation of Inflammation by Short Chain Fatty Acids
2011
Head and Neck Cancer
2020 Standout
Intensified and protective CD4+ T cell immunity in mice with anti–dendritic cell HIV gag fusion antibody vaccine
2006 StandoutNobel
MHCAttnNet: predicting MHC-peptide bindings for MHC alleles classes I and II using an attention-based deep neural model
2020
Tumor immune escape mechanisms: impact of the neuroendocrine system
2006
CTLA-4 blockade synergizes with tumor-derived granulocyte– macrophage colony-stimulating factor for treatment of an experimental mammary carcinoma
1998 StandoutNobel
Adoptive cell transfer as personalized immunotherapy for human cancer
2015 StandoutScience
Lysosomal cathepsin D mediates endogenous mucin glycodomain catabolism in mammals
2022 StandoutNobel
Cancer Immunoediting: Integrating Immunity’s Roles in Cancer Suppression and Promotion
2011 StandoutScience
B7-H1 Expression on Non-Small Cell Lung Cancer Cells and Its Relationship with Tumor-Infiltrating Lymphocytes and Their PD-1 Expression
2004
Identification of a promiscuous T-cell epitope encoded by multiple members of the MAGE family.
1999
Peptide-binding specificity prediction using fine-tuned protein structure prediction networks
2023 StandoutNobel
Does the Immune System See Tumors as Foreign or Self?
2003
Dendritic Cells as Adjuvants for Immune-mediated Resistance to Tumors
1997 StandoutNobel
In vivo priming of two distinct antitumor effector populations: the role of MHC class I expression.
1994
Simultaneous precise editing of multiple genes in human cells
2019 StandoutNobel
Neoantigens in cancer immunotherapy
2015 StandoutScience
Effector Memory T Cells, Early Metastasis, and Survival in Colorectal Cancer
2005 Standout
Enhancement of Antitumor Immunity by CTLA-4 Blockade
1996 StandoutScienceNobel
Growth Factors, Matrices, and Forces Combine and Control Stem Cells
2009 StandoutScience
CAR T cell immunotherapy for human cancer
2018 StandoutScience
Atezolizumab and Nab-Paclitaxel in Advanced Triple-Negative Breast Cancer
2018 Standout
Liquid phase condensation in cell physiology and disease
2017 StandoutScience
Combination Immunotherapy of B16 Melanoma Using Anti–Cytotoxic T Lymphocyte–Associated Antigen 4 (Ctla-4) and Granulocyte/Macrophage Colony-Stimulating Factor (Gm-Csf)-Producing Vaccines Induces Rejection of Subcutaneous and Metastatic Tumors Accompanied by Autoimmune Depigmentation
1999 StandoutNobel
Works of Ángel Concha being referenced
HLA molecules in basal cell carcinoma of the skin
1992
Real-Time RT-PCR Analysis for Evaluating the Her2/neu Status in Breast Cancer
2010
Presence of hpv 16 sequences in laryngeal carcinomas
1990
HLA class I expression and HPV‐16 sequences in premalignant and malignant lesions of the cervix
1993
Dietary Olive Oil Supplemented with Fish Oil, Rich in EPA and DHA (n-3) Polyunsaturated Fatty Acids, Attenuates Colonic Inflammation in Rats with DSS-Induced Colitis
2005
HER2 status in breast cancer: experience of a Spanish National Reference Centre
2011
HLA-DR expression is associated with excellent prognosis in squamous cell carcinoma of the larynx
1990
The intestinal anti‐inflammatory effect of quercitrin is associated with an inhibition in iNOS expression
2004
A comparative study of the preventative effects exerted by two probiotics,Lactobacillus reuteriandLactobacillus fermentum, in the trinitrobenzenesulfonic acid model of rat colitis
2007
Loss of HLA Heavy Chain and β2‐Microglobulin in HLA Negative Tumours
1991
Dietary Fiber Down-Regulates Colonic Tumor Necrosis Factor α and Nitric Oxide Production in Trinitrobenzenesulfonic Acid-Induced Colitic Rats
2002
Lack of MHC class I antigens and tumour aggressiveness of the squamous cell carcinoma of the larynx
1990
HLA Class I and II Expression in Rhabdomyosarcomas
1991
Conventional and molecular cytogenetic diagnostic methods in stem cell research: A concise review
2007
DIFFERENT PATTERNS OF HLA‐DR ANTIGEN EXPRESSION IN NORMAL EPITHELIUM, HYPERPLASTIC AND NEOPLASTIC MALIGNANT LESIONS OF THE BREAST
1995
The development of ‘feeder’ cells for the preparation of clinical grade hES cell lines: Challenges and solutions
2006
Promyelocytic leukemia (PML) nuclear bodies are disorganized in colorectal tumors with total loss of major histocompatibility complex class I expression and LMP7 downregulation
2004
Molecular analysis of MHC-class-I alterations in human tumor cell lines
1991
Can the HLA phenotype be used as a prognostic factor in breast carcinomas?
1991
Relationship of 4F2 antigen with local growth and metastatic potential of squamous cell carcinoma of the larynx
1990
MHC CLASS I AND II ANTIGENS ON GASTRIC CARCINOMAS AND AUTOLOGOUS MUCOSA
1989
Genome-wide differential genetic profiling characterizes colorectal cancers with genetic instability and specific routes to HLA class I loss and immune escape
2011
Implication of the β2-microglobulin gene in the generation of tumor escape phenotypes
2012
Microsatellite instability analysis in tumors with different mechanisms for total loss of HLA expression
2000
Histocompatibility antigens in primary and metastatic squamous cell carcinoma of the larynx
1989
Strategies for preventing immunologic rejection of transplanted human embryonic stem cells
2006
Altered HLA class I expression in non-small cell lung cancer is independent of c-myc activation
1992
Expression of HLA class I and II antigens in bronchogenic carcinomas: its relationship to cellular DNA content and clinical-pathological parameters.
1991
Preventative effects of a probiotic, Lactobacillus salivarius ssp. salivarius, in the TNBS model of rat colitis.
2005
Natural history of HLA expression during tumour development
1993
Intestinal anti-inflammatory activity of dietary fiber (Plantago ovata seeds) in HLA-B27 transgenic rats
2003
Class I major histocompatibility complex antigens and tumor ploidy in breast and bronchogenic carcinomas.
1997
Tumor aggressiveness and MHC class I and II antigens in laryngeal and breast cancer.
1991